MedKoo Cat#: 531329 | Name: PF-6274484
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PF-6274484 is an irreversible EGFR kinase inhibitor that covalently reacts with active-site cysteine residues in the ATP binding pocket. PF-6274484 inhibits autophosphorylation of both wild type and mutant EGFR in tumor cells with IC50 values of 5.8 nM and 6.6 nM, respectively.

Chemical Structure

PF-6274484
PF-6274484
CAS#1035638-91-5

Theoretical Analysis

MedKoo Cat#: 531329

Name: PF-6274484

CAS#: 1035638-91-5

Chemical Formula: C18H14ClFN4O2

Exact Mass: 372.0789

Molecular Weight: 372.78

Elemental Analysis: C, 58.00; H, 3.79; Cl, 9.51; F, 5.10; N, 15.03; O, 8.58

Price and Availability

Size Price Availability Quantity
10mg USD 280.00 2 Weeks
25mg USD 540.00 2 Weeks
50mg USD 920.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
PF-6274484; PF6274484; PF 6274484
IUPAC/Chemical Name
N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-2-propenamide
InChi Key
TUYDDIWQXWTNSW-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H14ClFN4O2/c1-3-17(25)24-15-7-11-14(8-16(15)26-2)21-9-22-18(11)23-10-4-5-13(20)12(19)6-10/h3-9H,1H2,2H3,(H,24,25)(H,21,22,23)
SMILES Code
C=CC(NC1=CC2=C(NC3=CC=C(F)C(Cl)=C3)N=CN=C2C=C1OC)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 372.78 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Schwartz, P. A., Kuzmic, P., Solowiej, J., Bergqvist, S., Bolanos, B., Almaden, C., ... & Murray, B. W. (2014). Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance. Proceedings of the National Academy of Sciences, 111(1), 173-178. Liu, X. (2017). Development of Novel Alkyne-Containing Inhibitors of Protein Kinases (Doctoral dissertation, University of Southern California).